New Haven, CT, United States of America

Donald M Engelman

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 249(Granted Patents)


Location History:

  • Guilford, CT (US) (1998 - 2011)
  • New Haven, CT (US) (2011 - 2024)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Donald M Engelman: A Career Marked by Outstanding Achievements and Contributions to Science

Introduction:

Donald M Engelman, an esteemed researcher and professor, has made exceptional contributions to the field of biological membranes throughout his illustrious career. With prestigious positions at Yale University and the Yale School of Medicine, Engelman has been recognized for his expertise and innovative research. This article will delve into his latest patents, highlight his notable career achievements, explore his collaborations, and shed light on his significant contributions to the field of science.

Latest Patents:

Engelman's innovative spirit is reflected in his latest patents. Among them are two notable inventions:

1. Liposome compositions and methods of use thereof:

This patent application introduces novel compositions comprising a liposome with a pH-Low Insertion Peptide (pHLIP) polypeptide. The invention focuses on utilizing liposomes with pHLIP polypeptides for various applications while ensuring that the lipid bilayer remains substantially free of the pHLIP polypeptide. This breakthrough has the potential to revolutionize drug delivery systems and targeted therapies.

2. Fluorescent compound comprising a fluorophore conjugated to a pH-triggered polypeptide:

Engelman's patent provides compounds, compositions, and methods for identifying, monitoring, treating, and removing diseased tissue. Additionally, it offers innovative approaches to detect and monitor circulating fluids such as blood. The development of this compound opens new avenues for disease diagnosis and treatment.

Career Highlights:

Engelman's career boasts impressive accomplishments, solidifying his status as a prominent figure in the field of biological membranes. Some of his notable career highlights include:

1. Professorships at Yale University and Yale School of Medicine:

Engelman held prestigious positions as a professor at both Yale University and the Yale School of Medicine. His tenure allowed him to impart knowledge to numerous aspiring scientists and contribute significantly to the educational realm.

2. Extensive research on the structure and function of biological membranes:

Engelman's primary research focus lies in the study of the structure and function of biological membranes. His in-depth investigations have led to groundbreaking discoveries and advancements, shaping the way we understand membrane biology.

Collaborations:

Engelman's exceptional work has been strengthened through collaborations with fellow scientists. Notable collaborators include:

1. Yana K Reshetnyak:

Engelman has collaborated with Yana K Reshetnyak on several research projects. Reshetnyak, a distinguished researcher herself, has expertise in membrane biology and cancer therapeutics. Their collaborative efforts have resulted in significant contributions to the field.

2. Oleg A Andreev:

Engelman's collaborations with Oleg A Andreev have paved the way for groundbreaking research in the field. Andreev's specialization in membrane biophysics and cancer biology complement Engelman's expertise, creating a synergy that has led to remarkable scientific advancements.

Conclusion:

Donald M Engelman's distinguished career, marked by numerous achievements and accolades, has greatly enriched our understanding of biological membranes. Through his exceptional research, innovative patents, and collaborations, Engelman has made substantial contributions to the scientific community. His groundbreaking work continues to inspire and pave the way for future advancements in the field of membrane biology and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…